Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients

Cytokine

Volumn 53, Issue 1, 2011, Pages 29-34

  Huang, Li feng ^a   Yao, Yong ming ^a   Dong, Ning ^a   Yu, Yan ^a   He, Li xin ^a   Sheng, Zhi yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cytokines; Immunosuppression; Inflammation; Mediator; Thermal injury

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; BLOOD SAMPLING; BURN PATIENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SURVIVAL RATE; THERMAL INJURY; UPREGULATION;

ADULT; BURNS; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; RNA, MESSENGER; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78349304687     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.09.010     Document Type: Article

References (47)

1. Development and validation of a model for prediction of mortality in patients with acute burn injury. Br J Surg 2009, 96:111-117. Belgian Outcome in Burn Injury Study Group.
2. Park J.O., Shin S.D., Kim J., Song K.J., Peck M.D. Association between socioeconomic status and burn injury severity. Burns 2009, 35:482-490.
3. Finnerty C.C., Przkora R., Herndon D.N., Jeschke M.G. Cytokine expression profile over time in burned mice. Cytokine 2009, 45:20-25.
4. Jennings C., Kusler B., Jones P.P. Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo. Innate Immun 2009, 15:109-120.
5. Roca F.J., Mulero I., López-Muñoz A., Sepulcre M.P., Renshaw S.A., Meseguer J., et al. Evolution of the inflammatory response in vertebrates: fish TNF-alpha is a powerful activator of endothelial cells but hardly activates phagocytes. J Immunol 2008, 181:5071-5081.
6. Ihle B.U. Clinical practice guidelines for improving outcomes in sepsis. Heart Lung Circ 2008, 17:S26-31.
7. Lavrentieva A., Kontakiotis T., Lazaridis L., Tsotsolis N., Koumis J., et al. Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis?. Burns 2007, 33:189-194.
8. Sama A.E., D'Amore J., Ward M.F., Chen G., Wang H. Bench to bedside. HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Acad Emerg Med 2004, 11:867-873.
9. Huang W, Tang Y, Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine. 2010 Mar 25. [Epub ahead of print].
10. Yuan Z., Chen J., Zhang Y., Peng Y. Construction and characterization of the HMGB1 mutant as a competitive antagonist to HMGB1 induced cytokines release. Biochem Biophys Res Commun 2008, 372:703-707.
11. Tang D., Shi Y., Kang R., Li T., Xiao W., Wang H., et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007, 81:741-747.
12. Unoshima M. Therapeutic effect of anti-HMGB1 antibody and anti-RAGE antibody on SIRS/sepsis. Nippon Rinsho 2004, 62:2323-2329.
13. Rauvala H., Rouhiainen A. RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease. Curr Mol Med 2007, 7:725-734.
14. Horvath E.E., Murray C.K., Vaughan G.M., Chung K.K., Hospenthal D.R., Wade C.E., et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg 2007, 245:978-985.
15. Lavrentieva A., Kontakiotis T., Bitzani M., Papaioannou-Gaki G., Parlapani A., Thomareis O., et al. Early coagulation disorders after severe burn injury: impact on mortality. Intensive Care Med 2008, 34:700-706.
16. Miyao M., Firestein G.S., Keithley E.M. Acoustic trauma augments the cochlear immune response to antigen. Laryngoscope 2008, 118:1801-1808.
17. Giannoudis P.V., Pape H.C. Trauma and immune reactivity: too much, or too little immune response?. Injury 2007, 38:1333-1335.
18. Schwacha M.G., Schneider C.P., Chaudry I.H. Differential expression and tissue compartmentalization of the inflammatory response following thermal injury. Cytokine 2002, 17:266-274.
19. Hagiwara S., Iwasaka H., Matsumoto S., Noguchi T. High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med 2008, 34:361-367.
20. Dong N., Jin B.Q., Yao Y.M., Yu Y., Cao Y.J., He L.X., et al. Change in T cell-mediated immunity and its relationship with high mobility group box-1 protein levels in extensively burned patients. Zhonghua Wai Ke Za Zhi 2008, 46:759-762.
21. Dong N., Yao Y.M., Yu Y., Gu C.Y., Lei S.H., Sheng Z.Y. Changes in plasma high mobility group box-1 protein levels in severely burned patients. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2007, 29:466-470.
22. Dong N., Yao Y.M., Cao Y.J., He L.X., Yu Y., Chai J.K., et al. The clinical significance of changes in immunological function of T lymphocyte in severe burn patients with sepsis. Zhonghua Shao Shang Za Zhi 2007, 23:84-87.
23. Greenhalgh D.G., Saffle J.R., Holmes J.H., Gamelli R.L., Palmieri T.L., Horton J.W., et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007, 28:776-790.
24. Poser I., Golob M., Buettner R., Bosserhoff A.K. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol 2003, 23:2991-2998.
25. Lyng M.B., Laenkholm A.V., Pallisgaard N., Ditzel H.J. Identification of genes for normalization of real-time RT-PCR data in breast carcinomas. BMC Cancer 2008, 22:20.
26. Church D., Elsayed S., Reid O., Winston B., Lindsay R. Burn wound infections. Clin Microbiol Rev 2006, 19:403-434.
27. Venet F., Tissot S., Debard A.L., Faudot C., Crampé C., Pachot A., et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med 2007, 35:1910-1917.
28. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008, 180:2531-2537.
29. Song H., Feng Y., Hoeger S., Beck G., Hanusch C., Goettmann U., et al. High mobility group box 1 and adenosine are both released by endothelial cells during hypothermic preservation. Clin Exp Immunol 2008, 152:311-319.
30. Aneja R.K., Tsung A., Sjodin H., Gefter J.V., Delude R.L., Billiar T.R., et al. Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. J Leukoc Biol 2008, 84:1326-1334.
31. Sundén-Cullberg J., Norrby-Teglund A., Rouhiainen A., Rauvala H., Herman G., Tracey K.J., et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005, 33:564-573.
32. Arimura N., Ki-I Y., Hashiguchi T., Sakamoto T., Maruyama I. High-mobility group box 1 protein in endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2008, 246:1053-1058.
33. Hagiwara S., Iwasaka H., Noguchi T. Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. J Anesth 2007, 21:164-170.
34. Muller M.J., Pegg S.P., Rule M.R. Determinants of death following burn injury. Br J Surg 2001, 88:583-587.
35. Zhang L.T., Yao Y.M., Dong Y.Q., Dong N., Yu Y., Sheng Z.Y. Relationship between high-mobility group box 1 protein release and T-cell suppression in rats after thermal injury. Shock 2008, 30:449-455.
36. Huang L.F., Yao Y.M., Meng H.D., Zhao X.D., Dong N., Yu Y., et al. The effect of high mobility group box-1 protein on immune function of human T lymphocytes in vitro. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2008, 20:7-13.
37. Zhang L.T., Yao Y.M., Lu J.Q., Yan X.J., Yu Y., Sheng Z.Y. Recombinant bactericidal/ permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis. Shock 2008, 29:278-284.
38. Huang L.F., Yao Y.M., Zhang L.T., Dong N., Yu Y., Sheng Z.Y. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 2009, 31:322-329.
39. Yao Y.M., Lin H.Y. The potential role of high mobility group box 1 protein in immune dysfunction and its regulatory mechanism after major trauma. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2008, 20:513-515.
40. Gibot S., Massin F., Cravoisy A., Barraud D., Nace L., Levy B., et al. High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 2007, 33:1347-1353.
41. Sakamoto Y., Mashiko K., Matsumoto H., Hara Y., Kutsukata N., Yamamoto Y. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients. ASAIO J 2007, 53:324-328.
42. Jeschke M.G., Mlcak R.P., Finnerty C.C., Norbury W.B., Gauglitz G.G., Kulp G.A., et al. Crit Care 2007, 11:R90.
43. van Zoelen M.A., Laterre P.F., van Veen S.Q., van Till J.W., Wittebole X., Bresser P., et al. Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med 2007, 35:2799-2804.
44. Dong N., Yao Y.M., Cao Y.J., He L.X., Chai J.K., Xu S., et al. Clinical significance of changes in quantitative expression of human leukocyte antigen DR in severely burned patients. Zhonghua Wai Ke Za Zhi 2007, 45:766-769.
45. Rice T.W. Treatment of Severe Sepsis: Where next? Current and future treatment approaches after the introduction of drotrecogin alfa. Vasc Health Risk Manag 2006, 2:3-18.
46. Wang H., Li W., Goldstein R., Tracey K.J., Sama A.E. HMGB1 as a potential therapeutic target. Novartis Found Symp 2007, 280:73-85. [discussion 85-91, 160-164].
47. Yao Y.M., Sheng Z.Y., Huang L.F. The effect of a novel cytokine, high mobility group box 1 protein, on the development of traumatic sepsis. Chin J Integr Med 2009, 15:13-15.